世界の製薬産業における事業提携、ライセンス、投資、M&A動向(2014年第4四半期版)...市場調査レポートについてご紹介

【英文タイトル】Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 11
2 Pharmaceuticals & Healthcare, Global, Deal Summary, Q4 2014 15
2.1 Pharmaceuticals & Healthcare, Global, Deals Analysis, Q4 2014 15
2.2 Pharmaceuticals & Healthcare, Global, by Type, Number of Deals, Q4 2014 17
2.3 Pharmaceuticals & Healthcare, Global, by Type, Deal Values, Q4 2014 18
2.4 Pharmaceuticals & Healthcare, Global, Top Deals, Q4 2014 19
2.4.1 Actavis to Acquire Allergan for USD66 Billion 19
2.4.2 Medtronic Raises USD17 Billion in Private Placement of Notes 20
2.4.3 Merck Acquires Cubist Pharma for USD9.5 Billion 20
2.4.4 Bayer Raises USD7 Billion in Public Offering Bonds 21
2.4.5 LabCorp to Acquire Covance for USD6.1 Billion 21
3 Pharmaceuticals & Healthcare, Global, Deals Summary, by Type 23
3.1 Pharmaceuticals & Healthcare, Global, M&A, Q4 2014 23
3.1.1 Top M&A Deals in Q4 2014 24
3.1.2 Pharmaceuticals & Healthcare, Global, M&A Deals, by Therapy Area, Q4 2013 – Q4 2014 25
3.2 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, Q4 2014 26
3.2.1 Top Initial Public Offerings in Q4 2014 27
3.2.2 Top Secondary Offerings in Q4 2014 28
3.2.3 Top PIPE Deals in Q4 2014 28
3.2.4 Pharmaceuticals & Healthcare, Global, Top IPOs Share Performance, Q4 2013-Q4 2014 29
3.2.5 Pharmaceuticals & Healthcare, Global, Equity Offering Deals, by Therapy Area, Q4 2013 – Q4 2014 29
3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, Q4 2014 31
3.3.1 Top Venture Financing Deals in Q4 2014 32
3.3.2 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 33
3.3.3 Pharmaceuticals & Healthcare, Global, Venture Capital Deals, by Stage of Financing, Q4 2014 34
3.3.4 Pharmaceuticals & Healthcare, Global, Venture Capital, by Therapy Area, Q4 2013 – Q4 2014 35
3.3.5 Pharmaceuticals & Healthcare, Global, Top Venture Financing Firms, Q4 2013 – Q4 2014 36
3.3.6 Pharmaceuticals & Healthcare, Global, Top VC Backed Companies, Q4 2013 – Q4 2014 37
3.4 Pharmaceuticals & Healthcare, Global, Private Equity Deals, Q4 2014 38
3.4.1 Top Private Equity Deals in Q4 2014 39
3.4.2 Pharmaceuticals & Healthcare, Global, Private Equity Deals, by Therapy Area, Q4 2013 – Q4 2014 40
4 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.1 Pharmaceuticals & Healthcare, Global, Partnership Deals, Q4 2014 42
4.2 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, Q4 2013 – Q4 2014 44
4.3 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2014 46
4.3.1 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Deal Values, Q4 2014 47
4.3.2 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Upfront Payment, Q4 2014 48
4.3.3 Pharmaceuticals & Healthcare, Global, Top Partnership Deals, by Milestone Payments, Q4 2014 48
4.4 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Therapy Area, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 49
4.5 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Number Of Deals, Q4 2013 – Q4 2014 51
4.6 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, Deal Values (US$ m), Q4 2013 – Q4 2014 52
4.7 Pharmaceuticals & Healthcare, Global, Partnership Deals, by Phase, by Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 53
5 Pharmaceuticals & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.1 Pharmaceutical & Healthcare, Global, Licensing Agreements, Q4 2014 55
5.2 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, Upfront & Milestone Payments and Deal Values (US$ m), Q4 2013 – Q4 2014 57
5.2.1 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Deal Value, Q4 2014 58
5.2.2 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Upfront Payments, Q4 2014 59
5.2.3 Pharmaceuticals & Healthcare, Global, Top Licensing Agreements, by Total Milestone Payment, Q4 2014 60
5.3 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Total Deal Value (US$ m), Q4 2013 – Q4 2014 61
5.4 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Therapy Area, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 63
5.5 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 65
5.6 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Total Deal Values (US$ m), Q4 2013 – Q4 2014 66
5.7 Pharmaceuticals & Healthcare, Global, Licensing Agreement Deals, by Phase, Upfront Payments Vs Milestone Payments (US$ m), Q4 2013 – Q4 2014 68
6 Pharmaceuticals & Healthcare, Global, M&A Financial Analysis 70
6.1 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value versus Median Deal Value, Q4 2013 – Q4 2014 70
6.2 Pharmaceuticals& Healthcare, Global Acquisitions, Average Price Earnings of Acquired Companies, Q4 2013 – Q4 2014 72
6.3 Pharmaceuticals & Healthcare, Global Acquisitions, Average EV/EBITDA of Acquired Companies, Q4 2013 – Q4 2014 73
6.4 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value per Operating Profit, Q4 2013 – Q4 2014 75
6.5 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Market Price Per Share, Q4 2013 – Q4 2014 77
6.6 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Share versus Average Book Value Per Share, Q4 2013 – Q4 2014 78
6.7 Pharmaceuticals & Healthcare, Global Acquisitions, Average Deal Value Per Sales, Q4 2013 – Q4 2014 79
7 Pharmaceuticals & Healthcare, Global, Deal Summary by Therapy Area 80
7.1 Pharmaceuticals & Healthcare, Global, Oncology Deals, Q4 2014 80
7.1.1 Oncology – Deals of the Quarter 82
7.2 Pharmaceuticals & Healthcare, Global, Central Nervous System Deals, Q4 2014 84
7.2.1 Central Nervous System – Deals of the Quarter 86
7.3 Pharmaceuticals & Healthcare, Global, Infectious Disease Deals, Q4 2014 88
7.3.1 Infectious Disease – Deals of the Quarter 89
7.4 Pharmaceuticals & Healthcare, Global, Immunology Deals, Q4 2014 92
7.4.1 Immunology – Deals of the Quarter 94
7.5 Pharmaceuticals & Healthcare, Global, Metabolic Disorders, Deals, Q4 2014 96
7.5.1 Metabolic Disorders – Deals of the Quarter 97
7.6 Pharmaceuticals & Healthcare, Global, Cardiovascular Deals, Q4 2014 100
7.6.1 Cardiovascular – Deals of the Quarter 101
7.7 Pharmaceuticals & Healthcare, Global, Gastrointestinal Deals, Q4 2014 103
7.7.1 Gastrointestinal – Deals of the Quarter 104
7.8 Pharmaceuticals & Healthcare, Global, Dermatology Deals, Q4 2014 106
7.8.1 Dermatology – Deals of the Quarter 107
7.9 Pharmaceuticals & Healthcare, Global, Respiratory Deals, Q4 2014 109
7.9.1 Respiratory – Deals of the Quarter 110
7.10 Pharmaceuticals & Healthcare, Global, Ophthalmology Deals, Q4 2014 113
7.10.1 Ophthalmology – Deals of the Quarter 114
8 Deal Summary by Geography 117
8.1 Pharmaceuticals & Healthcare, North America Region, Deals, Q4 2014 117
8.1.1 North America – Deals of the Quarter 119
8.2 Pharmaceuticals & Healthcare, Europe Region, Deals, Q4 2014 121
8.2.1 Europe – Deals of the Quarter 122
8.3 Pharmaceuticals & Healthcare, Asia-Pacific, Deals, Q4 2014 126
8.3.1 Asia-Pacific – Deals of the Quarter 127
8.4 Pharmaceuticals & Healthcare, Rest of the World, Deals, Q4 2014 129
8.4.1 Rest of the World – Deals of the Quarter 130
9 Pharmaceuticals & Healthcare, Global, Top Advisors 132
9.1 Pharmaceuticals & Healthcare, Global Top Financial Advisors, M&A, Q4 2013 – Q4 2014 132
9.2 Pharmaceuticals & Healthcare, Global, Top Financial Advisors, Equity Offerings, Q4 2013 – Q4 2014 134
10 Appendix 136
11 Further Information 139
11.1 Methodology 139
11.2 About GlobalData 140
11.3 Disclosure information 141
11.4 Disclaimer 141


【レポート販売概要】

■ タイトル:世界の製薬産業における事業提携、ライセンス、投資、M&A動向(2014年第4四半期版)
■ 英文:Partnerships, Licensing, Investments and M&A Deals and Trends in Pharmaceuticals - Q4 2014
■ 発行日:2015年2月15日
■ 調査会社:GlobalData
■ 商品コード:GDPH0473QD
■ 調査対象地域:グローバル
  • リチウムイオン電池の世界市場予測(~2022年):コバルト酸リチウム、リン酸鉄リチウム、リチウム・ニッケル・マンガン・コバルト
    “Lithium ion battery market expected to exhibit significant growth potential between 2016 and 2022”The lithium ion battery market is expected to grow at a CAGR of 16.6% between 2016 and 2022 to be valued at USD 68.97 billion by 2022. The key driving factors for the growth of the lithium ion battery market are increase in demand for electric vehicle, strict government mandates on fuel economy, grow …
  • 世界の屋内LBS市場動向(2012-2016)
    TechNavio's analysts forecast the Global Indoor Location-based Service (LBS) market to grow at a CAGR of 40.05 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing adoption of local area networks. The Global Indoor LBS market has also been witnessing the increasing deployment of indoor LBS solutions in universities. However, the low-level a …
  • ワクチンの世界市場2016-2020
    About Human Vaccine According to the Centers for Disease Control and Prevention (CDC), a vaccine is a product that stimulates a person’s immune system to produce immunity to a specific disease, protecting the person from that disease. Vaccines are usually administered through needle injections, but can also be administered by mouth or sprayed into the nose. Human vaccines are of two types: prevent …
  • リファビッシュ(再生)医療機器の世界市場2016-2020
    About Refurbishment Refurbishment involves restoring equipment to its original condition without altering any of the product's specifications. The process ensures maintenance of the safety and efficacy of the medical equipment without altering its performance. Therefore, refurbishment varies from the replacement of worn parts to cosmetic changes to complete the end-to-end manufacturing process. Us …
  • MCADソフトウェアの世界市場
    About MCAD Software MCAD software is used for modeling and designing of critical parts, components, and structures. The software assists engineers, architects, and other design professionals to develop superior quality products in the market. It enables end-users to simulate a product's real-world performance by digitally prototyping its creation. The software are used across industries such as In …
  • 臍帯血バンクサービスの世界市場2015-2022
    According to Stratistics MRC, the Cord Blood Banking Services market accounted for $12.50 billion in 2015 and is expected to grow at a CAGR of 6.41% to reach $19.32 billion by 2022. The factors such as increasing stem cell therapy applications in diseased treatments, growing number of advancements in technologies, rising awareness of cord blood banking services and growing incidence in prevalence …
  • 電動スクーター・バイクの世界市場予測(~2027年)
    “Demand for electric two-wheelers and subsidies provided by governments are significant factors for the growth of the electric scooter and motorcycle market globally” The global electric scooter and motorcycle market is estimated to grow from 684 thousand units in 2019 to reach 7,919 thousand by 2027, at a CAGR of 35.8%. Increased emphasis on reduction in carbon emissions is expected to boost the …
  • 生体認証センサーの世界市場2016-2020
    About biometric sensors A biometric sensor is a transducer, which converts the biometric input signal (fingerprints, voice, vein patterns, or facial traits) of its user into an electrical signal. In order to authenticate any biometric measurement, a biometric sensor is required to scan the user's fingerprint or voice or face in the hardware set. Technavio’s analysts forecast the global biometric s …
  • エアースポーツ用品の世界市場2019-2023
    About this market Rising number of training programs and courses for different air sports to drive market growth. Over the past decade, air sports have witnessed a tremendous surge in popularity. Several basic and advanced training programs are available for people to learn the technicalities of such sports activities. These training schools have highly qualified and experienced instructors and pi …
  • 世界のインタラクティブ・ホワイトボード(電子黒板)市場(2014-2018)
    About Interactive Whiteboards An IWB is an interactive display system that projects images stored in a computer and allows users to control screen activities using a pen, stylus, or finger. The IWB was introduced to facilitate the teachers in the classrooms for delivering the content. The growing popularity and the efforts from the vendors have also helped in its penetration in the Corporate and G …
  • 農業用染料・色素の世界市場予測(~2020)
    The agricultural dyes & pigments market is projected to grow at a CAGR of 4.3% from 2015 to reach a projected value of USD 1.86 Billion by 2020. The market growth is driven by increasing demand from end-user industries such as fertilizer industry, turf & ornamental industry & pond/lake color management industry. Further, the increasing number of applications such as use of dyes & pigments in seed …
  • レーザー加工の世界市場:固体レーザー、液体レーザー、ガスレーザー
    MarketsandMarkets forecasts the laser processing market to grow from USD 6.40 Billion in 2015 to USD 9.75 Billion by 2022, at a CAGR of 6.13% from 2016 to 2022. The major factors driving the growth of this market include diversified application areas of lasers, adoption of lasers for material processing, increased demand for high-quality and genuine end products, and miniaturization of electronic …
  • 海底生産及び加工システムの世界市場2016-2026
    Visiongain assesses that CAPEX on subsea production and processing systems will total $16.36bn in 2016. This includes spending on umbilicals, risers, flowlines, controls, trees, manifolds and tie-ins. Large deepwater subsea projects can take up to ten years from final investment decision to start-up date. Smaller tiebacks can be completed within two years. It is therefore critical that you have yo …
  • Beta-2 Microglobulin:医療検査市場2014
    The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technolog …
  • RFID in Agriculture
    RFID in Agriculture provides the reader with an understanding of RFID and its current and future use in agriculture systems, processes, and procedures. This report reveals the path traversed by RFID, evaluating some of the most important implementations of RFID within the agriculture and food industries. Throughout this report there are real life facts with figures so that the reader can judge the …
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。